Kevin O’Laughlin

机构：Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention · ORCID：0000-0001-9484-683X

发表论文 34 篇 · 总被引 1900 次 · h-index 16

代表论文

• Characteristics Associated with Hospitalization Among Patients with COVID-19 — Metropolitan Atlanta, Georgia, March–April 2020 (2020 · MMWR Morbidity and Mortality Weekly Report · 被引 389)
• Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, October 2019 (2019 · MMWR Morbidity and Mortality Weekly Report · 被引 267)
• Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022 (2022 · MMWR Morbidity and Mortality Weekly Report · 被引 206)
• Characteristics of a Multistate Outbreak of Lung Injury Associated with E-cigarette Use, or Vaping — United States, 2019 (2019 · MMWR Morbidity and Mortality Weekly Report · 被引 186)
• Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022 (2022 · MMWR Morbidity and Mortality Weekly Report · 被引 139)
• Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries — United States, October 2019 (2019 · MMWR Morbidity and Mortality Weekly Report · 被引 128)